Please login to the form below

Not currently logged in
Email:
Password:

Road wins Helperby Therapeutics account

Agency will provide communications support to the antibiotics firmN

ROADLondon-based healthcare comms agency Road has been appointed by Helperby Therapeutics to provide communications around its work on antimicrobial resistance.

Road will be launching offline, digital and social media programmes to engage the medical and investment communities in conversations around antibiotics and resistance.

Helperyby is working on antiobiotic technology that it hopes will battle microbial resistance by combining new resistance breakers with existing antibiotics to create a “new generation of therapies”.

Frances Crewsdon, chief operating officer at Helperby, said: “There has been no new class of antibiotic produced over thirty years.

“This new lease of life for antibiotics has the potential to help sustain our defence against life threatening superbugs for years to come.”

The threat of antimicrobial resistance continues to attract a high-level response, most recently with the EU bringing together stakeholders across Europe last month to define common policies to fight AMR and control hospital-acquired infections.

Article by
Gemma Jones

2nd October 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics